Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation | MicrobiomeTrials← Back to trialsNCT07549503
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-14Est. Completion: 2031-04-01
Enrollment target: 100 participants Locations- UCSF Benioff Children's Hospital, San Francisco, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
- Emory University School of Medicine/Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Columbia University Medical Center, New York, New York, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States
Other microbiome trials you might be interested in
Pancreatitis, Chronic; Diabetes; Transplant
Patients with severe chronic pancreatitis may be candidates to have their pancreas removed and their islets transplanted…
Minneapolis, United StatesCompleted Jul 1, 2023
Alcohol Use DisorderAlcoholic Hepatitis
Given the severe consequences of alcohol relapse following liver transplantation for alcoholic hepatitis (AH-LT), it is …
Baltimore, United StatesEst. completion Jun 2027
Ada Chao